Abstract:Background: Brain-derived neurotrophic factor (BDNF) has been implicated in the pathophysiology of heroin dependence. BDNF expression is dramatically changed during drug withdrawal, and is associated with drug withdrawal syndrome. This study aimed to explore (1) alterations of BDNF serum levels in heroin-dependent patients after long term abstinence; and (2) the association between BDNF serum levels and protracted withdrawal syndrome.Method: Fifty-three male heroin-dependent patients and fifty-two gender-matched healthy controls were enrolled in this study. We measured BDNF serum levels at baseline and 26 weeks after heroin abstinence. Moreover, protracted withdrawal symptoms, depression and anxiety symptoms were measured by Protracted Withdrawal Symptoms of Heroin-dependent patients (PWSHA), Self-rating Depression Scale (SDS) and Self-rating Anxiety Scale (SAS), respectively.Result: We found that baseline BDNF serum levels were significantly lower in heroin-dependent patients compared to controls (p < 0.01). There was also a significantly difference in BDNF serum levels among heroin-dependent patients at baseline and 26-week follow-up (p < 0.01). The BDNF serum levels were not associated with age, BMI, years of education, age of initial use, or duration of use. Of the clinical symptoms measured, the change in BDNF serum levels from baseline to 26-week follow-up was negatively associated with the change in PWSHA scores (r = 0.44, p < 0.01, see Table 2 and Figure 2 for details).Conclusion: The results show that the BDNF serum levels in heroin-dependent patients are lower than those of healthy controls at baseline and increased after 26 weeks of abstinence, although the BDNF serum levels are still lower than those of the healthy controls. A negative correlation between the change in BDNF serum levels and protracted withdrawal symptoms was found but needs to be confirmed in further study. The results revealed that BDNF serum level is worth paying attention to in order to further investigate the possibility of it being a biomarker of treatment outcome for opiate dependence. (C) 2015 Elsevier Inc. All rights reserved.

Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal.

Brain-derived Neurotrophic Factor Levels and Depression During Methamphetamine Withdrawal.

Repeated Methamphetamine Exposure Decreases Plasma Brain-Derived Neurotrophic Factor Levels in Rhesus Monkeys.

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users

Brain-derived Neurotrophic Factor Serum Levels in Heroin-Dependent Patients after 26weeks of Withdrawal.

BDNF–TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms

Increased Serum Brain-Derived Neurotrophic Factor Levels During Opiate Withdrawal.

Regional-specific changes in rat brain BDNF in a model of methamphetamine abuse

Dynamic Immune and Exosome Transcriptomic Responses in Patients Undergoing Psychostimulant Methamphetamine Withdrawal

Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence

Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis

Abnormal static and dynamic amplitude of low-frequency fluctuations in multiple brain regions of methamphetamine abstainers

Plasma BDNF and TrkB mRNA in PBMCs Are Correlated With Anti-depressive Effects of 12-Weeks Supervised Exercise During Protracted Methamphetamine Abstinence

Analysis of serum metabonomics in patients with methamphetamine induced withdrawal disorder in nervous system

Dopamine transporter dysfunction in Han Chinese people with chronic methamphetamine dependence after a short-term abstinence.

Acute and protracted abstinence from methamphetamine bidirectionally changes intrinsic excitability of indirect pathway spiny projection neurons in the dorsomedial striatum

Selective Activation of Striatal NGF-TrkA/p75NTR/MAPK Intracellular Signaling in Rats That Show Suppression of Methamphetamine Intake 30 Days following Drug Abstinence

Association Between Serum Malondialdehyde Levels and Depression During Early Methamphetamine Withdrawal

The metabolic impact of methamphetamine on the systemic metabolism of rats and potential markers of methamphetamine abuse.

[Change of Brain Structure Imaging of Long-Term Withdrawal of Methamphetamine-Dependent Patients].

Neurotoxic Methamphetamine Doses Alter CDCel-1 Levels and Its Interaction with Vesicular Monoamine Transporter-2 in Rat Striatum